GlassScriptPhysician profile
Erika Hawes
NPI 1578114658
$662.74
in general payments reported to CMS, 2019-2025
20 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.77 · 2024: $143 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $103.18 | 2024-2025 | |
| Astellas Pharma US INC | $66.57 | 2025 | Veozah |
| Novo Nordisk INC | $64.59 | 2025 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.68 | 2024-2025 | Xifaxan |
| Exact Sciences Corporation | $43.32 | 2025 | The Cologuard Plus Collection Kit |
| Celgene Corporation | $40.11 | 2024 | Zeposia |
| Radius Health, INC. | $31.32 | 2025 | Tymlos |
| Optinose US, INC. | $27.72 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.06 | 2025 | Vpriv |
| Pfizer INC. | $25.45 | 2025 | |
| Boston Scientific Corporation | $25.45 | 2025 | Watchman Flx |
| Janssen Biotech, INC. | $22.43 | 2024 | Stelara |
| Lilly USA, LLC | $20.48 | 2025 | Jardiance |
| Masimo Corporation | $18.77 | 2022 | |
| Merck Sharp & Dohme LLC | $17.67 | 2025 | Gardasil 9, Capvaxive |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.58 | 2025 | Onpattro |
| Seqirus USA INC | $17.03 | 2025 | Fluad, Flucelvax |
| Eisai INC. | $16.36 | 2025 | |
| Amgen INC. | $16.05 | 2025 | Repatha |
| Medicure Pharma INC. | $14.92 | 2025 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Hawes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.